Visible results often appear within a month, especially when Tirzepatide is combined with supportive care
It may even lead to overdose
They may recommend more frequent thyroid function monitoring, especially if you are taking oral semaglutide
This formulation effectively suppressed the initial burst release down to 10%, and maintained therapeutic plasma drug concentrations for a month [69]
Reduces risk of cardiovascular diseases With its ability to enhance insulin sensitivity, lower blood glucose levels, and decrease weight, tirzepatide is considered to have the potential to manage cardiovascular diseases, such as hypertension and heart disease
The subcutaneous route is good for those who cant get intramuscular shots or have certain health issues